| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
03-24-2016, 10:20 AM
|
#1 | |||
|
||||
|
Senior Member
|
Results
Most studies reported a reduction in peripheral GDNF and its mRNA levels in MDD patients versus controls. In contrast, IGF-1 levels in MDD patients compared to controls were discrepant across studies. Finally, most studies reported high peripheral VEGF levels and mRNA expression in MDD patients compared to healthy controls. Conclusions GDNF, IGF-1 and VEGF levels and their mRNA expression appear to be differentially altered in MDD patients compared to healthy individuals, indicating that these molecules might play an important role in the pathophysiology of depression and antidepressant action of therapeutic interventions. http://www.jad-journal.com/article/S...stract?rss=yes
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Missing link found between brain, immune system; major disease implications | Parkinson's Disease | |||
| Elevated Serum Pesticide Levels and Risk for Alzheimer Disease | Alzheimer's Disease | |||
| Serum metal levels | Parkinson's Disease | |||
| Question Re: Serum Magnesium & Potassium Levels | General Health Conditions & Rare Disorders | |||
| In animal model, VitD3 increased GDNF mRNA levels in striatum | Parkinson's Disease | |||
Depressed serum GDNF levels in major depression--implications for PD?
Linear Mode
